GROVE CITY (November 23, 2021) – Mount Carmel Health System today announced plans to further strengthen its oncology program at Mount Carmel Grove City through an affiliation with The James Cancer Network at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute’s (OSUCCC – James), effective Jan. 1, 2022.

Together with The James Cancer Network, Mount Carmel physicians and clinicians will have access to additional research, quality improvement programs and tumor boards that will expand the health system’s existing capabilities for cancer care. Mount Carmel Grove City’s state-of-the-art Cancer Center has become known for its exceptional patient care; now, the center will offer medical oncology services to further advance its impact and care experience. In addition to the radiation oncology and cancer services already provided by Mount Carmel, we will now offer medical oncology through The James Cancer Network in our Cancer Center, which enhances the continuum of care for patients and makes it easier for patients to receive convenient, high-quality cancer care in their community.

“The James is a well-established and highly respected cancer research and cancer care provider for patients not only in central Ohio, but across the world,” said Lorraine Lutton, president and CEO at Mount Carmel Health System. “As caregivers, it brings us great pride to be able to provide world-renowned cancer care in Grove City and to areas where there is tremendous demand for this type of highly specialized care. This collaboration is a monumental step towards that accessibility.”

Bringing the expertise of The James Cancer Network to Mount Carmel Grove City enables patients to have coordinated access to cancer subspecialists and clinical research, expands the scope and services of the oncology program at Mount Carmel and ensures the community can receive cancer care in Grove City minimizing the need for travel and discomfort.

“Expanding access to high-quality, subspecialized cancer care and clinical trials while minimizing the travel burden for patients and families is a priority at the OSUCCC – James,” says James CEO William B. Farrar, MD. “Through this affiliation with Mount Carmel Grove City, patients in our community will have expanded access to some of the most innovative and research-based medical oncology services available anywhere in the nation. This new affiliation enables us to reach more cancer patients while extending our shared vision of creating a cancer-free world.”

Currently, Mount Carmel’s Cancer Center in Grove City offers diagnostic services and integrated, multidisciplinary care for all types of cancers, performing more than 35,000 outpatient treatments, 3,500 inpatient treatments and 2,600 cancer surgeries each year.

For more information on Mount Carmel Health System and OSUCCC, visit www.mountcarmelhealth.com or www.cancer.osu.edu.

About Mount Carmel Health System
Mount Carmel Health System, a member of Trinity Health, has provided high-quality, comprehensive healthcare services in central Ohio for more than 130 years. Our team of more than 9,000 colleagues, 2,000 physicians and 550 volunteers provide compassionate, people-centered primary and specialty care at our four hospitals—Mount Carmel East, Mount Carmel Grove City, Mount Carmel New Albany and Mount Carmel St. Ann’s, along with Diley Ridge Medical Center, an affiliation of Mount Carmel and Fairfield Medical Center. The health system is comprised of Mount Carmel Medical Group and Mount Carmel Health Partners’ network of physicians. MediGold, a Medicare Advantage health insurance plan, and the Mount Carmel College of Nursing, one of Ohio's largest baccalaureate nursing degree programs, are also integral members of the health system. Mount Carmel also includes surgery centers, emergency and ambulatory care centers, and hospice and home care services.

About the OSUCCC – James
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors and with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit www.cancer.osu.edu.